Walder Wyss advised the shareholders of Saiba Animal Health in the sale of all shares to the biopharmaceutical company Boehringer Ingelheim. With the acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&
Walder Wyss advised the shareholders of Saiba Animal Health in the sale of all shares to the biopharmaceutical company Boehringer Ingelheim. With the acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&